SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-04-022923
Filing Date
2004-12-28
Accepted
2004-12-28 13:09:33
Documents
5
Period of Report
2004-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v010433.txt 8-K 4961
2 v010433_ex4-5.txt EX-4.5 23391
3 v010433_ex4-6.txt EX-4.6 23390
4 v010433_ex10-7.txt EX-10.7 8110
5 v010433_ex10-8.txt EX-10.8 8161
  Complete submission text file 0001144204-04-022923.txt   70241
Mailing Address SUITE 103-158TH HILLSIDE AVE. VICTORIA A1 00000
Business Address SUITE 103-158TH HILLSIDE AVE. VICTORIA A1 00000 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-61610 | Film No.: 041228012
SIC: 4822 Telegraph & Other Message Communications